PIK3CA mutations are found in approximately 20–40% of endometrial cancers, predominantly in high-grade tumors and in cancers classified as serous or clear cell subtypes, which are more aggressive and poorly differentiated [67]. The gene discussed is PIK3CA; the disease is cancer.